CRISPR/Cas Gene-Editing Technique Holds Great Promise, but Research Moratorium Makes Sense Pending Further Study 
        
            By Jeff Bessen, 
                 The Conversation 
             | 07. 29. 2015
        
                    
                                    
                    
                                                                                                                                    
                                                                            
                              
    
  
  
    
  
          
  
      
    
             
  Untitled Document 
  
CRISPR/Cas is a new technology that allows unprecedented control over   the DNA code. It’s sparked a revolution in the fields of genetics and   cell biology, becoming the scientific equivalent of a household name by   raising hopes about new ways to cure diseases including cancer and to   unlock the remaining mysteries of our cells.
 
  The gene editing technique also raises concerns. Could the new tools   allow parents to order “designer babies”? Could premature use in   patients lead to unforeseen and potentially dangerous consequences? This   potential for abuse or misuse led prominent scientists to call for a halt on some types of new research until ethical issues can be discussed – a voluntary ban that was swiftly ignored in some quarters.
 
  The moratorium is a positive step toward preserving the public’s   trust and safety, while the promising new technology can be further   studied.
 
  Editing DNA to cure disease
 
  While most human diseases are caused, at least partially, by mutations in our DNA, current   therapies treat the symptoms of these mutations but not the genetic root   cause. For example, cystic fibrosis...
 
 
  
 
    
    
  
   
                        
                                                                                
                 
                                                    
                            
                                  
    
  
  
      Related Articles
    
  
          
  
  
  
  
  
  
      
            
                  
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Katie Hunt,  CNN | 07.30.2025
                                                        
     
    
    
            Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick,  Issues in Science and Technology | 07.04.2025
                                                        
     
    
    
            
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Pallab Gosh and Gwyndaf Hughes,  BBC News | 06.26.2025
                                                        
     
    
    
            
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi,  MIT Technology Review | 03.25.2025
                                                        
     
    
    
            
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...